产品
编 号：F301417
分子式：C7H6N4O2
分子量：178.15
分子式：C7H6N4O2
分子量：178.15
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
询价
询价
50mg
询价
询价
100mg
询价
询价
200mg
询价
询价
结构图
CAS No: 27314-97-2
产品详情
生物活性：
Tirapazamine (SR259075) is an anticancer agent that shows selective cytotoxicity for hypoxic cells in solid tumors, thereby inducing single-and double-strand breaks in DNA, base damage, and cell death. Tirapazamine is an anticancer and bioreductive agent.Tirapazamine (SR259075) can enhance the cytotoxic effects of ionizing radiation in hypoxic cells.
体内研究：
Tirapazamine (SR259075) (1mg; intravenously injected; twice at a 24-h interval) shows a synergetic effect to kill tumor cells because TPZ was activated under the hypoxic conditions that originated from the PDT with Pba and laser irradiation..Animal Model:C3H/HeN mice.
Dosage:1mg
Administration:Tirapazamine (1mg; intravenously injected; twice at a 24-h interval)
Result:Suppressed the tumors of mice by using laser irradiation.
体外研究：
Tirapazamine (SR259075) is the optimal drug for combination therapy using Pba.
Tirapazamine (SR259075) is an anticancer agent that shows selective cytotoxicity for hypoxic cells in solid tumors, thereby inducing single-and double-strand breaks in DNA, base damage, and cell death. Tirapazamine is an anticancer and bioreductive agent.Tirapazamine (SR259075) can enhance the cytotoxic effects of ionizing radiation in hypoxic cells.
体内研究：
Tirapazamine (SR259075) (1mg; intravenously injected; twice at a 24-h interval) shows a synergetic effect to kill tumor cells because TPZ was activated under the hypoxic conditions that originated from the PDT with Pba and laser irradiation..Animal Model:C3H/HeN mice.
Dosage:1mg
Administration:Tirapazamine (1mg; intravenously injected; twice at a 24-h interval)
Result:Suppressed the tumors of mice by using laser irradiation.
体外研究：
Tirapazamine (SR259075) is the optimal drug for combination therapy using Pba.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备